Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-25-120106

Chief Executive Officer sold 200,000 shares at an average $14.87 ($2,974,700)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Santos da Silva Jorge Chief Executive Officer 2025-12-08 Sale −130,000 $15.08 $1,960,400 2,948,577 D: show line 1 in the form
Santos da Silva Jorge Chief Executive Officer 2025-12-09 Sale −70,000 $14.49 $1,014,300 2,878,577 D: show line 2 in the form
Open-market sales · 200,000 sh · avg $14.87 · $2,974,700
Loading xslF345X05/ownership.xml…